NEW YORK, NY / ACCESSWIRE / July 13, 2020 / Jakubowitz Law announces that securities fraud class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies who purchased shares within the class periods listed below. Shareholders interested in representing the class of wronged shareholders have until the lead plaintiff deadline to petition the court. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. For more details and to speak with our firm without cost or obligation, follow the links below.
Grand Canyon Education, Inc. (NASDAQ:LOPE)
CONTACT JAKUBOWITZ ABOUT LOPE:
https://claimyourloss.com/securities/grand-canyon-education-inc-loss-submission-form/?id=7920&from=1
Class Period: January 5, 2018 - January 27, 2020
Lead Plaintiff Deadline: July 13, 2020
According to a filed complaint, statements made by Defendants were false and/or misleading because following Grand Canyon's spin-off of its educational assets as Grand Canyon University ("GCU"): (i) GCU would not be a proper non-profit organization as it would remain under the control of Grand Canyon, and (ii) Grand Canyon would not be a third-party service provider to GCU but rather would continue to effectively operate the entity, and (iii) Grand Canyon employees served as executives of GCU and (iv) GCU functioned as an off-balance-sheet entity to which Grand Canyon would be able to funnel expenses and costs in exchange for a disproportionate amount of revenue, thereby inflating Grand Canyon's financial results.
Co-Diagnostics, Inc. (NASDAQ:CODX)
CONTACT JAKUBOWITZ ABOUT CODX:
https://claimyourloss.com/securities/co-diagnostics-inc-loss-submission-form/?id=7920&from=1
Class Period: February 25, 2020 - May 15, 2020
Lead Plaintiff Deadline: August 17, 2020
According to the filed complaint, Co-Diagnostics and its directors and officers (including PhD-level scientists who should know better) made continual, knowing, and willful misstatements about the Company's main product, a Covid-19 diagnostic test. These misstatements had the effect of pumping up the price of Co-Diagnostics' stock, while Company officers and directors exercised low-priced options and dumped their stock into the market. Co-Diagnostics' fraudulent misstatements displayed a disregard for basic scientific principles and caused investors to lose millions of dollars.
Kirkland Lake Gold Ltd. (NYSE:KL)
CONTACT JAKUBOWITZ ABOUT KL:
https://claimyourloss.com/securities/kirkland-lake-gold-ltd-loss-submission-form/?id=7920&from=1
Class Period: January 8, 2018 - November 25, 2019
Lead Plaintiff Deadline: August 28, 2020
The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (i) Kirkland lacked adequate internal controls over financial reporting, especially as it relates to its projections of risks, reserve grade, and all-in sustaining costs; (ii) as a result of the known, but undisclosed, impending acquisition of Detour, the Company's projections relating to its risks, reserve grade, and all-in sustaining costs were false and misleading; (iii) the Company's financial statements and projections were not fairly presented in conformity with International Financial Reporting Standards; (iv) based on the foregoing, Defendants lacked a reasonable basis for their positive statements about the Company's business, operations, and prospects and/or lacked a reasonable basis and omitted material facts.
Jakubowitz Law is vigorous in pursuit of justice for shareholders who have been the victim of securities fraud. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
JAKUBOWITZ LAW
1140 Avenue of the Americas
9th Floor
New York, New York 10036
T: (212) 867-4490
F: (212) 537-5887
SOURCE: Jakubowitz Law
View source version on accesswire.com:
https://www.accesswire.com/597286/LAWSUITS-FILED-AGAINST-LOPE-CODX-and-KL--JAKUBOWITZ-LAW-PURSUES-SHAREHOLDERS-CLAIMS
